PRQR

Proqr Therapeutics Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 0/10
  • Value↓ 0/10
Proqr Therapeutics sales and earnings growth
PRQR Growth
Low
  • Revenue Y/Y↓ -30.60%
  • EPS Y/Y↓ -34.38%
  • FCF Y/Y↓ -25.07%
Proqr Therapeutics gross and profit margin trends
PRQR Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -333.50%
  • ROIC 5Y↓ -1134.66%
Proqr Therapeutics net debt vs free cash flow
PRQR Risk
Great
  • Debt / Equity↓ 0.4
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -28.7

Proqr Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks